2016-03-11T00:00:00.000-05:00
bladder cancer,-0.576809
cancer patients,-0.540317
data,-0.0144606
Chris Marai,-0.233117
CSF1 receptor,-0.299169
response rate,0.191019
bladder cancer patients,-0.694694
mesothelioma arm,0.387376
tumor microenvironment,-0.104266
strong balance sheet,0.631501
thanks,0.687489
patients,0.0171654
squamous non-small cell,-0.544471
question,0.0545216
clinical programs,0.599957
trial,0.192105
gastric cancer patients,-0.545344
little bit,-0.136014
Eun Yang,0.388849
Dr. Rusty Williams,-0.428153
dose escalation,-0.295201
mesothelioma patients,-0.437226
clinical data,0.278533
cell lung cancer,-0.544471
tumor,0.012372
refractory gastric cancer,-0.415213
GSK,0.29722
kennen mackay,0.202945
additional patients,-0.0274739
gastric cancer,-0.514682
Rusty Williams,-0.633463
tumor growth,0.501207
comprehensive protein library,0.515965
dose escalation portion,-0.246878
clinical trial,-0.379661
mesothelioma,0.199422
mesothelioma data,0.335624
Jim Birchenough,0.325764
advisory board meeting,0.216074
mesothelioma trial,0.428377
immune cells,-0.524922
